{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:57:41Z","timestamp":1793750261565,"version":"4.6.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-21880-z","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:21:09Z","timestamp":1761830469000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Elucidating the underlying mechanism of mechanical stress-induced impact on mRNA-LNP structure"],"prefix":"10.1038","volume":"15","author":[{"given":"Erika L.","family":"Jensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Chih","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanliu Leah","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Matthessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Goffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofie","family":"Van Hees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga V.","family":"Friese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robbe","family":"Van Pottelberge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"key":"21880_CR1","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41586-021-03275-y","volume":"592","author":"AB Vogel","year":"2021","unstructured":"Vogel, A. B. et al. BNT162b vaccines protect rhesus macaques from SARS-CoV-2. Nature 592, 283\u2013289. https:\/\/doi.org\/10.1038\/s41586-021-03275-y (2021).","journal-title":"Nature"},{"key":"21880_CR2","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1056\/NEJMoa2024671","volume":"383","author":"KS Corbett","year":"2020","unstructured":"Corbett, K. S. et al. Evaluation of the mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates. N. Engl. J. Med. 383, 1544\u20131555. https:\/\/doi.org\/10.1056\/NEJMoa2024671 (2020).","journal-title":"N. Engl. J. Med."},{"key":"21880_CR3","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/s41565-019-0591-y","volume":"14","author":"A Akinc","year":"2019","unstructured":"Akinc, A. et al. The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs. Nat. Nanotechnol. 14, 1084\u20131087. https:\/\/doi.org\/10.1038\/s41565-019-0591-y (2019).","journal-title":"Nat. Nanotechnol."},{"key":"21880_CR4","doi-asserted-by":"publisher","first-page":"6777","DOI":"10.1038\/s41467-021-26926-0","volume":"12","author":"M Packer","year":"2021","unstructured":"Packer, M., Gyawali, D., Yerabolu, R., Schariter, J. & White, P. A novel mechanism for the loss of mRNA activity in lipid nanoparticle delivery systems. Nat. Commun. 12, 6777. https:\/\/doi.org\/10.1038\/s41467-021-26926-0 (2021).","journal-title":"Nat. Commun."},{"key":"21880_CR5","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.xphs.2023.11.023","volume":"113","author":"U Chheda","year":"2024","unstructured":"Chheda, U. et al. Factors affecting stability of RNA\u2014temperature, length, concentration, pH, and buffering species. J. Pharm. Sci. 113, 377\u2013385. https:\/\/doi.org\/10.1016\/j.xphs.2023.11.023 (2024).","journal-title":"J. Pharm. Sci."},{"key":"21880_CR6","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.1093\/nar\/gkad124","volume":"8","author":"R Guth-Metzler","year":"2023","unstructured":"Guth-Metzler, R. et al. Goldilocks and RNA: where Mg2+ concentration is just right. Nucleic Acids Res. 8, 3529\u20133539. https:\/\/doi.org\/10.1093\/nar\/gkad124 (2023).","journal-title":"Nucleic Acids Res."},{"key":"21880_CR7","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1261\/rna.5680603","volume":"9","author":"GM Emilsson","year":"2003","unstructured":"Emilsson, G. M., Nakamura, S., Roth, A. & Breaker, R. R. Ribozyme speed limits. RNA 9, 907\u2013918. https:\/\/doi.org\/10.1261\/rna.5680603 (2003).","journal-title":"RNA"},{"key":"21880_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2024.10.012","author":"R Van Pottelberge","year":"2024","unstructured":"Van Pottelberge, R. et al. Importance of RNase monitoring during large-scale manufacturing and analysis of mRNA-LNP based vaccines. J. Pharm. Sci. https:\/\/doi.org\/10.1016\/j.xphs.2024.10.012 (2024).","journal-title":"J. Pharm. Sci."},{"key":"21880_CR9","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/asia.201901205","volume":"15","author":"K Le Vay","year":"2020","unstructured":"Le Vay, K., Salibi, E., Song, E. Y. & Mutschler, H. Nucleic acid catalysis under potential prebiotic conditions. Chem. Asian J. 15, 214\u2013230. https:\/\/doi.org\/10.1002\/asia.201901205 (2020).","journal-title":"Chem. Asian J."},{"key":"21880_CR10","doi-asserted-by":"publisher","first-page":"120586","DOI":"10.1016\/j.ijpharm.2021.120586","volume":"601","author":"L Schoenmaker","year":"2021","unstructured":"Schoenmaker, L. et al. mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability. Int. J. Pharm. 601, 120586. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120586 (2021).","journal-title":"Int. J. Pharm."},{"key":"21880_CR11","doi-asserted-by":"publisher","first-page":"2303370","DOI":"10.1002\/adma.202303370","volume":"35","author":"MHY Cheng","year":"2023","unstructured":"Cheng, M. H. Y. et al. Induction of bleb structures in lipid nanoparticle formulations of mRNA leads to improved transfection potency. Adv. Mater. 35, 2303370. https:\/\/doi.org\/10.1002\/adma.202303370 (2023).","journal-title":"Adv. Mater."},{"key":"21880_CR12","doi-asserted-by":"publisher","first-page":"124942","DOI":"10.1016\/j.ijpharm.2024.124942","volume":"668","author":"B Binici","year":"2025","unstructured":"Binici, B., Borah, A., Watts, J. A., McLoughlin, D. & Perrie, Y. The influence of citrate buffer molarity on mRNA-LNPs: Exploring factors beyond general critical quality attributes. Int. J. Pharm. 668, 124942. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124942 (2025).","journal-title":"Int. J. Pharm."},{"key":"21880_CR13","doi-asserted-by":"publisher","first-page":"e100203","DOI":"10.1136\/bmjos-2021-100203","volume":"5","author":"L Kudsiova","year":"2021","unstructured":"Kudsiova, L. et al. Stability testing of the Pfizer-BioNTech BNT162b2 COVID-19 vaccine: A translational study in UK vaccination centres. BMJ Open Sci. 5, e100203. https:\/\/doi.org\/10.1136\/bmjos-2021-100203 (2021).","journal-title":"BMJ Open Sci."},{"key":"21880_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bpj.2021.03.012","volume":"120","author":"ML Brader","year":"2021","unstructured":"Brader, M. L. et al. Encapsulation state of messenger RNA inside lipid nanoparticles. Biophys. J. 120, 1\u20135. https:\/\/doi.org\/10.1016\/j.bpj.2021.03.012 (2021).","journal-title":"Biophys. J."},{"key":"21880_CR15","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.3390\/pharmaceutics14112357","volume":"14","author":"M Kamiya","year":"2022","unstructured":"Kamiya, M. et al. Stability study of mRNA-Lipid nanoparticles exposed to various conditions based on the evaluation between physicochemical properties and their relation with protein expression ability. Pharmaceutics 14, 2357. https:\/\/doi.org\/10.3390\/pharmaceutics14112357 (2022).","journal-title":"Pharmaceutics"},{"key":"21880_CR16","doi-asserted-by":"publisher","first-page":"114265","DOI":"10.1016\/j.ejpb.2024.114265","volume":"198","author":"A Ruppl","year":"2024","unstructured":"Ruppl, A. et al. Don\u2019t shake it! Mechanical stress testing of mRNA-lipid nanoparticles. Eur. J. Pharm. Biopharm. 198, 114265. https:\/\/doi.org\/10.1016\/j.ejpb.2024.114265 (2024).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"21880_CR17","doi-asserted-by":"publisher","first-page":"19590","DOI":"10.1038\/s41598-024-70680-4","volume":"14","author":"R Matthessen","year":"2024","unstructured":"Matthessen, R., Van Pottelberge, R., Goffin, B. & De Winter, G. Impact of mixing and shaking on mRNA-LNP drug product quality characteristics. Sci. Rep. 14, 19590. https:\/\/doi.org\/10.1038\/s41598-024-70680-4 (2024).","journal-title":"Sci. Rep."},{"key":"21880_CR18","doi-asserted-by":"publisher","first-page":"10336","DOI":"10.1038\/s41598-025-94616-8","volume":"15","author":"HL Wang","year":"2025","unstructured":"Wang, H. L. et al. A novel in-vitro expression assay by LC\/MS\/MS enables multi-antigen mRNA vaccine characterization. Sci. Rep. 15, 10336. https:\/\/doi.org\/10.1038\/s41598-025-94616-8 (2025).","journal-title":"Sci. Rep."},{"key":"21880_CR19","doi-asserted-by":"publisher","first-page":"16744","DOI":"10.1038\/s41598-023-43898-x","volume":"13","author":"MM Wang","year":"2023","unstructured":"Wang, M. M. et al. Elucidation of lipid nanoparticle surface structure in mRNA vaccines. Sci. Rep. 13, 16744. https:\/\/doi.org\/10.1038\/s41598-023-43898-x (2023).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21880-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21880-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21880-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:21:09Z","timestamp":1761830469000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21880-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["21880"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-21880-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,30]]},"assertion":[{"value":"10 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors are employees of Pfizer Manufacturing NV Belgium and Pfizer Inc New York at the time the work was performed.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38009"}}